More insight on the effect of PKG modulators on PKGs will not only be beneficial in IRDs but also for cancer research, as PKG activators have been shown to reduce cell proliferation, activate cell death and limit cell invasion in different cancer cell models [11,12,13,14,15,16]. This evidence concerns the gene PRKG1 and respiratory distress syndrome in premature infants.